New back injection aims to shrink painful disc bulges
NCT ID NCT06022263
Summary
This early-stage study tested the safety of an experimental injection called STA363 for people with sciatica caused by a herniated disc in the lower back. Twenty-five participants received either the STA363 injection or a placebo directly into the problem disc. Researchers monitored for side effects and checked if the treatment reduced the size of the disc bulge and eased leg pain over six months.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for LUMBAR DISC HERNIATION are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Samodzielny Publiczny Szpital Kliniczny nr 4, Klinika Ortopedii i Rehabilitacji
Lublin, Lublin Voivodeship, 20-002, Poland
Conditions
Explore the condition pages connected to this study.